Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIODARONE vs OSIMERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIODARONE vs OSIMERTINIB: Safety Overview

Metric AMIODARONE OSIMERTINIB
Total FAERS Reports 25,143 27,750
Deaths Reported 3,845 12,456
Death Rate 15.3% 44.9%
Hospitalizations 13,711 5,277
Average Patient Age 69.9 yrs 68.2 yrs
% Female Patients 36.9% 66.0%
FDA Approval Date Apr 12, 2005 Nov 13, 2015
Manufacturer Aurobindo Pharma Limited AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Discontinued Prescription